A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer

被引：0
|
作者：
Ava Kwong
L. P. Wong
H. N. Wong
F. B. F. Law
E. K. O. Ng
Y. H. Tang
W. K. Chan
L. S. Ho
K. H. Kwan
M. Poon
T. T. Wong
F. C. S. Leung
S. W. W. Chan
M. W. L. Ying
E. S. K. Ma
J. M. Ford
机构：
[1] The University of Hong Kong,Division of Breast Surgery, Queen Mary and Tung Wah Hospital
[2] Hong Kong Sanatorium and Hospital,Department of Molecular Pathology
[3] Hong Kong Sanatorium and Hospital,Department of Pathology
[4] Hong Kong Sanatorium and Hospital,Department of Surgery
[5] Princess Margaret Hospital,The Hong Kong Hereditary and High Risk Breast Cancer Programme
[6] Tuen Mun Hospital,undefined
[7] Queen Elizabeth Hospital,undefined
[8] Pamela Youde Nethersole Hospital,undefined
[9] United Christian Hospital,undefined
[10] Kwong Wah Hospital,undefined
[11] Stanford University School of Medicine,undefined
[12] The Hong Kong Hereditary Breast Cancer Family Registry,undefined
来源：
Breast Cancer Research and Treatment | 2009年 / 117卷
关键词：
BRCA Mutation; Male Breast Cancer; Recurrent Mutation; Male Breast Cancer Patient; Deleterious BRCA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：683 / 686
页数：3
相关论文
共 50 条
  • [41] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
    Petrucelli, Nancie
    Daly, Mary B.
    Feldman, Gerald L.
    GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
  • [42] Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
    Giuseppe Giannini
    Carlo Capalbo
    Elisabetta Ristori
    Enrico Ricevuto
    Tina Sidoni
    Amelia Buffone
    Enrico Cortesi
    Paolo Marchetti
    Giovanni Scambia
    Silverio Tomao
    Christian Rinaldi
    Massimo Zani
    Sergio Ferraro
    Luigi Frati
    Isabella Screpanti
    Alberto Gulino
    Breast Cancer Research and Treatment, 2006, 100 : 83 - 91
  • [43] BRCA2 mutations in hereditary breast and ovarian cancer in France
    SerovaSinilnikova, OM
    Boutrand, L
    StoppaLyonnet, D
    BressacdePaillerets, B
    Dubois, V
    Lasset, C
    Janin, N
    Bignon, YJ
    Longy, M
    Maugard, C
    Lidereau, R
    Leroux, D
    Frebourg, T
    Mazoyer, S
    Lenoir, GM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (05) : 1236 - 1239
  • [44] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    CANCER RESEARCH, 2016, 76
  • [45] Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries
    Kwong, Ava
    Shin, Vivian Y.
    Ho, John C. W.
    Kang, Eunyoung
    Nakamura, Seigo
    Teo, Soo-Hwang
    Lee, Ann S. G.
    Sng, Jen-Hwei
    Ginsburg, Ophira M.
    Kurian, Allison W.
    Weitzel, Jeffrey N.
    Siu, Man-Ting
    Law, Fian B. F.
    Chan, Tsun-Leung
    Narod, Steven A.
    Ford, James M.
    Ma, Edmond S. K.
    Kim, Sung-Won
    JOURNAL OF MEDICAL GENETICS, 2016, 53 (01) : 15 - 23
  • [46] BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
    Niell, BL
    Rennert, G
    Bonner, JD
    Almog, R
    Tomsho, LP
    Gruber, SB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (01): : 15 - 21
  • [47] BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
    Friedenson, B
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15): : 1184 - 1185
  • [48] Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients
    Anna P. Sokolenko
    Tatiana N. Sokolova
    Valeria I. Ni
    Elena V. Preobrazhenskaya
    Aglaya G. Iyevleva
    Svetlana N. Aleksakhina
    Alexandr A. Romanko
    Alexandr A. Bessonov
    Tatiana V. Gorodnova
    Elena I. Anisimova
    Elena L. Savonevich
    Ilya V. Bizin
    Ilya A. Stepanov
    Petr V. Krivorotko
    Igor V. Berlev
    Alexey M. Belyaev
    Alexandr V. Togo
    Evgeny N. Imyanitov
    Breast Cancer Research and Treatment, 2020, 184 : 229 - 235
  • [49] High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
    Maksimenko, J.
    Irmejs, A.
    Trofimovics, G.
    Berzina, D.
    Skuja, E.
    Purkalne, G.
    Miklasevics, E.
    Gardovskis, J.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2018, 16
  • [50] Investigation of three founder mutations in BRCA1 and BRCA2 in Iranian breast cancer patients
    Houshmand, M.
    Rassi, H.
    EJC SUPPLEMENTS, 2007, 5 (08): : 25 - 26
12345